Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 12/20 | 0.56 |
| ▸ | SLC6A11 | P48066 | 1/20 | 0.56 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.55 |
| ▸ | BCHE | P06276 | 8/20 | 0.54 |
| ▸ | CTSD | P07339 | 3/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7607375 | 1.00 | BACE1 (0.56) | BACE1SLC6A11PLA2G1BPOLBATG4B | |
| SCHEMBL7607369 | 1.00 | BACE1 (0.56) | BACE1SLC6A11PLA2G1BPOLBATG4B | |
| SCHEMBL7607624 | 0.87 | BACE1 (0.58) | BACE1SLC6A11BCHECTSD | |
| SCHEMBL7607629 | 0.87 | BACE1 (0.58) | BACE1SLC6A11BCHECTSD | |
| SCHEMBL6894836 | 0.87 | BACE1 (0.58) | BACE1SLC6A11BCHECTSD | |
| SCHEMBL7614224 | 0.86 | BACE1 (0.62) | BACE1SLC6A11BCHE | |
| SCHEMBL7614214 | 0.86 | BACE1 (0.62) | BACE1SLC6A11BCHE | |
| SCHEMBL7610032 | 0.86 | BACE1 (0.71) | BACE1SLC6A11BCHE | |
| SCHEMBL7610027 | 0.86 | BACE1 (0.71) | BACE1SLC6A11BCHE | |
| SCHEMBL6896189 | 0.85 | BACE1 (0.58) | BACE1SLC6A11BCHECTSD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2004502669-A | — | — | 2004-01-29 | — | — | JP | claimed |
| EP-1353898-A2 | COMPOUNDS TO TREAT ALZHEIMER'S DISEASE | Elan Pharmaceuticals, Inc. (US) | 2003-10-22 | — | — | EP | claimed |
| WO-2002002512-A2 | COMPOUNDS TO TREAT ALZHEIMER'S DISEASE | ELAN PHARMACEUTICALS, INC. (US) | 2002-01-10 | — | — | WO | claimed |